KALV Kalvista Pharmaceuticals Inc

KalVista Pharmaceuticals Inc is a pharmaceuticals company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases.

$21.28  +0.78 (3.81%)
As of 07/28/2021 15:57:04 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  04/09/2015
Outstanding shares:  24,436,492
Average volume:  244,874
Market cap:   $518,786,725
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    483497103
ISIN:        US4834971032
Sedol:      BD06CS0

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   1.95
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%